EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4633-4644

  Hu Lieskovan, Siwen ^a   Zhang, Jingsong ^a   Wu, Lingtao ^a   Shimada, Hiroyuki ^a   Schofield, Deborah E ^a   Triche, Timothy J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CYTOKERATIN 18; HYBRID PROTEIN; RNA BINDING PROTEIN EWS; SMALL INTERFERING RNA; TAU PROTEIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; EWING SARCOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROTUBULE; MOUSE; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NEURAL CREST; NEUROECTODERM TUMOR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL; UPREGULATION; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEURAL CREST; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEIN C-FLI-1; RHABDOMYOSARCOMA, EMBRYONAL; SARCOMA, EWING'S; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 19644386697     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2857     Document Type: Article

References (55)

1. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-9.
2. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992;359: 162-5.
3. Thiele CJ. Biology of pediatric peripheral neuroectodermal tumors. Cancer Metastasis Rev 1991;10: 311-9.
4. Cavazzana AO, Miser JS, Jefferson J, Triche TJ. Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 1987;127:507-18.
5. Noguera R, Triche TJ, Navarro S, Tsokos M, Llombart-Bosch A. Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters. Lab Invest 1992;66:143-51.
6. Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 1995;11:1049-54.
7. Deneen B, Denny CT. Loss of p 16 pathways stabilizes EVVS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 2001;20:6731-41.
8. Lessnick SL, Dacwag CS, Golub TR. The Ewing's sarcoma oncoprotein EWS/FL1 induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 2002;1:393-401.
9. Torchia EC, Jaishankar S, Baker SJ. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res 2003;63:3464-8.
10. Eliazer S, Spencer J, Ye D, Olson E, Ilaria RL Jr. Alteration of mesodermal cell differentiation by EWS/ FLI-I. the oncogene implicated in Ewing's sarcoma. Mol Cell Biol 2003;23:482-92.
11. Rorie CJ, Thomas VD, Chen P, Pierce HH. O'Bryan IP. Weissman BE. The Ews/Fli-I fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Res 2004;64:1266-77.
12. Teitell MA, Thompson AD. Sorensen PH. Shimada H, Triche TJ, Denny CT. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts. Lab Invest 1999;79:1535-43.
13. Sorensen PH, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EVVS/FLI1 fusion gene. Cancer Res 1995;55:1385-92.
14. Tan SY. Burchill S, Brownhill SC, et al. Small round cell tumor with biphenotypic differentiation and variant of t(21;22)(q22;q12). Pediatr Dev Pathol 2001;4:391-6.
15. Thorner P, Squire J, Chilton-MacNeil S, et al. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Am J Pathol 1996;148:1125-38.
16. James AC, Veitch JG, Zareh AR, Triche T. Sensitivity and specificity of five abundance estimators for high-density oligonucleotide microarrays. Bioinformatics 2004;20:1060-5.
17. Zhang J, Hu S, Schofield D, Sorensen P, Triche TJ. Selective usage of D type cyclins by Ewing's tumors and rhabdomyosarcomas. Cancer Res 2004;64:6026-34.
18. Dohjima T, Sook Lee N, Li H, Ohno T, Rossi JJ. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line. Mol Ther 2003;7:811-6.
19. Golub GH, van Loan CF. Matrix computations. Baltimore (MD): Johns Hopkins University Press; 1990.
20. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschjk M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886-93.
21. Hubert RS, Vivanco I, Chen E, et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A 1999;96:14523-8.
22. Dauphinot L, De Oliveira C, Melot T, et al. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression. Oncogene 2001;20:3258-65.
23. Nishimori H, Sasaki Y, Yoshida K, et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 2002;21:8302-9.
24. Fukuma M, Okita H, Hata J, Umezawa A. Upregulation of Id2. an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene 2003;22:1-9.
25. Matsumoto Y, Tanaka K, Nakatani F, Matsunobu T, Matsuda S, Iwamoto Y. Downregulation and forced expression of EWS-FliI fusion gene results in changes in the expression of G(1)regulatory genes. Br J Cancer 2001;84:768-75.
26. Hahm KB, Cho K, Lee C, et al. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 1999: 23:222-7.
27. Nakatani F, Tanaka K, Sakimura R, et al. Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J Biol Chem 2003;278: 15105-15.
28. 1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 1998;17:1027-37.
29. Cenciarelli C, De Santa F, Purl PL. et al. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol 1999;19:5203-17.
30. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004;303:1483-7.
31. LaBonne C, Bronner-Fraser M. Molecular mechanisms of neural crest formation. Annu Rev Cell Dev Biol 1999;15:81-112.
32. Perez-Losada J, Gutierrez-Cianca N, Sanchez-Garcia I. Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell. Leuk Lymphoma 2001;42:569-76.
33. Khan J, Wei JS, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9.
34. Streit A, Stern CD. Establishment and maintenance of the border of the neural plate in the chick: involvement of FGF and BMP activity. Mech Dev 1999;82:51-66.
35. Nagarajan R, Svaren J, Le N, Araki T, Watson M. Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001;30:355-68.
36. Foerst-Potts L, Sadler TW. Disruption of Msx-1 and Msx-2 reveals roles for these genes in craniofacial, eye. and axial development. Dev Dyn 1997;209:70-84.
37. Bellmeyer A, Krase J, Lindgren J, LaBonne C. The protooncogene c-myc is an essential regulator of neural crest formation in Xenopus. Dev Cell 2003;4: 827-39.
38. Martinsen BJ, Bronner-Fraser M. Neural crest specification regulated by the helix-loop-helix repressor Id2. Science 1998;281:988-91.
39. Bamforth SD, Braganca J, Eloranta JJ, et al. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 2001;29:469-74.
40. Barbera JP, Rodriguez TA, Greene ND, et al. Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet 2002;11:283-93.
41. Ballard VL, Mikawa T. Constitutive expression of preproendothelin in the cardiac neural crest selectively promotes expansion of the adventitia of the great vessels in vivo. Dev Biol 2002;251:167-77.
42. Simonneau L, Thiery JP. The mesenchymal cadherin-11 is expressed in restricted sites during the ontogeny of the rat brain in modes suggesting novel functions. Cell Commun Adhes 1998;6:431-50.
43. Borchers A, David R, Wedlich D. Xenopus cadherin-11 restrains cranial neural crest migration and influences neural crest specification. Development 2001;128: 3049-60.
44. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-9.
45. Inoue K, Ozaki S, Shiga T, et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 2002;5:946-54.
46. Friedman JM, Vitale M, Maimon J, Israel MA, Horowitz ME, Schneider BS. Expression of the chole-cystokinin gene in pediatric tumors. Proc Natl Acad Sci USA 1992;89:5819-23.
47. Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline. ectodermal. endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 2002;69:908-17.
48. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000;407:592-8.
49. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 2001;3:683-6.
50. Odelberg SJ, Kollhoff A, Keating MT. Dedifferentiation of mammalian myotubes induced by msx1. Cell 2000;103:1099-109.
51. Mehra-Chaudhary R, Matsui H, Raghow R. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. Biochem J 2001;353:13-22.
52. Braganca J, Eloranta JJ, Bamforth SD. Ibbitt JC, Hurst HC, Bhattacharya S. Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem 2003;278: 16021-9.
53. Garcia-Castro Ml, Marcelle C, Bronner-Fraser M. Ectodermal Wnt function as a neural crest inducer. Science 2002;297:848-51.
54. LaBonne C, Bronner-Fraser M. Induction and patterning of the neural crest a stem cell-like precursor population. J Neurobiol 1998;36:175-89.
55. -/- colon carcinoma. Science 1997;275:1784-7.